當(dāng)前位置：首頁 > 技術(shù)文章 > Biosynth 發(fā)展歷程

Biosynth 發(fā)展歷程

更新時(shí)間：2026-04-21 點(diǎn)擊次數(shù)：211

Biosynth發(fā)展歷程與介紹：

2019年Biosynth與Carbosynth合并成為Biosynth Carbosynth，致力于為全球客戶提供糖類核苷類和酶類產(chǎn)品。

2022年Biosynth集團(tuán)收購了vivitide和Pepscan兩家公司，用以鞏固其多肽類產(chǎn)品業(yè)務(wù)及相關(guān)配套生產(chǎn)技術(shù)服務(wù)。同年又收購了Aalto Bio Reagents公司以擴(kuò)大其關(guān)鍵生物制劑業(yè)務(wù)，包括用于臨床診斷的抗原抗體產(chǎn)品線。同時(shí)集團(tuán)也收購了EUCODIS Bioscience以鞏固其在酶技術(shù)領(lǐng)域的優(yōu)勢。

2023年Biosynth集團(tuán)收購美國Fitzgerald公司以及英國Cambridge Research Biochemicals公司，使其全球抗原抗體產(chǎn)品線擴(kuò)大至57000+種，并進(jìn)一步充實(shí)其多肽及抗體產(chǎn)品的相關(guān)服務(wù)能力。

貨號(hào)	品名	規(guī)格	品牌
PLP-3780-PI	Phe4,9 [Ring D5]-Hepcidin (Rat)	0.1mg	biosynth
STP-3621-PI-5mg	Ac-Phe-Thiaphe-OH	5mg	biosynth
EM35421	4-Methylumbelliferyl palmitate	1g	biosynth
EM15597	4-Methylumbelliferyl caprylate	1g	biosynth
crb1100420-0.4mg	Cathepsin G FRET substrate [5-FAM]/[6-TAMRA]	0.4mg	biosynth
crb1101508j	[5-FAM]/[Lys(Dabcyl)]-CoV Main Protease (Mpro) Substrate 1mg	1mg	biosynth
CRB2005004-20ug	Anti-Peroxiredoxin SO2/3 antibody	20ug	biosynth
OL01699	Laminaritriose	10mg	biosynth
D-8823-5g	n-Dodecyl-beta-D-maltoside	5g	biosynth
EM01930-25mg	4-Methylumbelliferyl a-L-fucopyranoside	25mg	biosynth
NM181126	N2-Methylguanosine	1mg	biosynth
EM05134	4-Methylumbelliferyl b-D-galactopyranoside-6-sulphate sodium salt - Moscerdam biochemical purity	25mg	biosynth
NM08574	N1-Methylguanosine	5mg	biosynth
ND05647	N2,N2-Dimethylguanosine	5mg	biosynth
MA05068-1mg	D-Arabinose-5-phosphate disodium salt	1mg	biosynth
MD03540	2-Deoxy-2-fluoro-D-mannose	25mg	biosynth
MB32165-1g	Blue dextran (MW 2000000) - from Leuconostoc spp	1g	biosynth
FH29659	trans-3-Hydroxy-L-proline	50mg	biosynth
H2N-IPAE(Cam)TTIYNR-OH	H2N-IPAE(Cam)TTIYNR-OH 11 residues >95％ Purity Amino Acid Analysis (AAA) - No (Cam) = Cys-CAM (carbamidomethylation)	50mgs	biosynth
JZB56909	Lalistat 2	2mg	biosynth

上一篇：GMA-8023/GMA-8024區(qū)別
下一篇：biovectra品牌介紹